Search

Your search keyword '"Ciafaloni, E."' showing total 226 results

Search Constraints

Start Over You searched for: Author "Ciafaloni, E." Remove constraint Author: "Ciafaloni, E."
226 results on '"Ciafaloni, E."'

Search Results

1. D.4 Safety and efficacy of delandistrogene moxeparvovec versus placebo in Duchenne muscular dystrophy (EMBARK): Pivotal Phase 3 primary results

3. Detecting early signs in Duchenne muscular dystrophy: comprehensive review and diagnostic implications

4. Minimal manifestation status and prednisone withdrawal in the MGTX trial

5. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy : A Randomized Clinical Trial

7. The relationship between deficit in digit span and genotype in nonsense mutation Duchenne muscular dystrophy

8. DMD – THERAPY

9. DMD & BMD – CLINICAL

11. DMD & BMD – CLINICAL

12. DMD & BMD – CLINICAL

13. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

14. P.02Phase 2/3 study of Arimoclomol in sporadic inclusion body myositis: study design

15. Randomized Trial of Thymectomy in Myasthenia Gravis

16. Widespread tissue distribution of a tRNA-Leu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome

17. Randomized trial of thymectomy in myasthenia gravis

18. Randomized trial of thymectomy in myasthenia gravis

20. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis

21. Pharmacokinetics of 21-desacetyldeflazacort and the safety of deflazacort after oral administration to children and adolescents with Duchenne muscular dystrophy

22. Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years--four states, 2007

23. T.P.2

34. O04 Efficacy of mexiletine in non-dystrophic myotonia: results of an international multi-centred randomised controlled trial

43. Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy

46. Clinical features associated with the a → g transition at nucleotide 8344 of mtdna (“merrf mutation”)

47. MELAS: Clinical features, biochemistry, and molecular genetics

48. Widespread tissue distribution of a trnaleu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome

49. A G+1->A transversion at the 5' splice site of intron 69 of the dystrophin gene causing the absence of peripheral nerve Dp 116 and severe clinical involvement in a DMD patient

Catalog

Books, media, physical & digital resources